Evan G. Pappas
St. Vincent's Institute
Fitzroy, VIC 3065, Australia
Fitzroy, VIC 3065, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Optimised modular anti-FLAG CAR T cells for solid tumor therapy.
Journal: Clinical & translational immunology
Published: March 26, 2025
Extraislet expression of islet antigen boosts T cell exhaustion to partially prevent autoimmune diabetes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 29, 2024
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.
Journal: Cancers
Published: February 01, 2023
Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor.
Journal: Clinical & translational immunology
Published: April 25, 2022
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
Journal: Molecular metabolism
Published: September 17, 2021
Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse.
Journal: Cell reports
Published: August 22, 2021
Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: March 12, 2021
Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice.
Journal: Frontiers in immunology
Published: December 24, 2020
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
Journal: Diabetologia
Published: July 29, 2020
The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice.
Journal: Frontiers in immunology
Published: July 29, 2020
Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Journal: Diabetologia
Published: June 11, 2019
Last Updated: 09/26/2026